Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRCA Verrica Pharmaceuticals Inc. Common Stock
$3.20 -10.11% -0.36
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRCA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Verrica Pharmaceuticals Inc. Common Stock (VRCA)

Loading

Key Stats

Market cap. 55.0M
Enterprise value 73.1M
Trailing PE -1.907738049825
Forward PE -2.6080585
PEG Ratio 0.00059616814057032
Enterprise to EBITDA -1.84
Enterprise to revenue 3.193
Price to book MRQ 15.853866612388
Price to sales TTM 2.6716387

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 22.9M
EBITDA -39729000
Diluted EPS TTM -2.3
Total Cash (MRQ) 14.4M
Current ratio (MRQ) 1.89
Operating Cash Flow (TTM) -17627000

VRCA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRCA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.